32 postdoc-in-distributed-systems-and-controls Fellowship positions at Nature Careers in Uk
-
date: No closing date 23:59 GMT About us… The Francis Crick Institute is Europe’s largest biomedical research institute under one roof. Our world-class scientists and staff collaborate on vital research
-
, Birmingham UK Full time starting salary is normally in the range £43,455 to £73,506 Clinical Full Time, Fixed Term contract up to 1 year 2 positions available Closing date: 23rd July 2025 Background
-
Position Details School of Biosciences Location: University of Birmingham, Edgbaston, Birmingham UK Full time starting salary is normally in the range £36,130 to £45,413 with potential progression
-
Position Details School of Chemistry, College of Engineering and Physical Sciences Location: University of Birmingham, Edgbaston, Birmingham UK Full time starting salary is normally in the range
-
Position Details School of Computer Science Location: University of Birmingham, Edgbaston, Birmingham UK Full time starting salary is normally in the range £36,130 to £45,413 with potential
-
Position Details School of Chemistry, College of Engineering and Physical Sciences Location: University of Birmingham, Edgbaston, Birmingham UK Full time starting salary is normally in the range
-
this link. About the John Innes Centre: The John Innes Centre is an independent, international centre of excellence in plant and microbial sciences. We nurture a creative, curiosity-led approach to answering
-
Position Details School of Biosciences Location: University of Birmingham, Edgbaston, Birmingham UK Full time starting salary is normally in the range £36,130 to £45,413 with potential progression
-
Position Details School of Biosciences Location: University of Birmingham, Edgbaston, Birmingham UK Full time starting salary is normally in the range £34,980 to £44,263 with potential progression
-
diseases. About the project Mitochondrial DNA (mtDNA) dysfunction causes a range of devastating human disorders, for which there is currently no effective treatment. The Spinazzola & Holt group has